Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myasthenia Gravis (MG)”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Large-scale testing (Phase 3)Looking for participantsNCT06799247
What this trial is testing

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

Who this might be right for
Myasthaenia Gravis
Cartesian Therapeutics 100
Not applicableLooking for participantsNCT06967480
What this trial is testing

Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisAnti-AChR Antibody Positive
Alexion Pharmaceuticals, Inc. 40
Early research (Phase 1)Looking for participantsNCT06680037
What this trial is testing

Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

Who this might be right for
B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc. 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04146051
What this trial is testing

Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

Who this might be right for
Myasthenia Gravis, Generalized
Cartesian Therapeutics 30
Early research (Phase 1)Study completedNCT05451212
What this trial is testing

Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis

Who this might be right for
MuSK Myasthenia Gravis
Cabaletta Bio 7
Testing effectiveness (Phase 2)Study completedNCT04728425
What this trial is testing

Subcutaneous Immunoglobulin for Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
University Health Network, Toronto 30
Large-scale testing (Phase 3)Study completedNCT05039190
What this trial is testing

Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients

Who this might be right for
Myasthenia Gravis
Harbour BioMed (Guangzhou) Co. Ltd. 132
Large-scale testing (Phase 3)Looking for participantsNCT06607627
What this trial is testing

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisgMG
Alexion Pharmaceuticals, Inc. 12
Very early researchLooking for participantsNCT07337785
What this trial is testing

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Who this might be right for
Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1 more
Daishi Tian 36
Early research (Phase 1)Looking for participantsNCT06869278
What this trial is testing

LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disease (NMOSD)Anti-Myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders (MOGAD)+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 37
Large-scale testing (Phase 3)Not Yet RecruitingNCT06684184
What this trial is testing

Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG)

Who this might be right for
Myasthaenia Gravis
Zhongming Qiu 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07215949
What this trial is testing

Zilucoplan for Severe gMG Exacerbations

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Miriam Freimer 15
Not applicableLooking for participantsNCT06617741
What this trial is testing

Myasthenia Gravis Foundation of America Global MG Patient Registry

Who this might be right for
Myasthaenia GravisMyastheniaMyasthenia Gravis Associated with Thymoma+10 more
Myasthenia Gravis Foundation of America 3,800
Large-scale testing (Phase 3)Study completedNCT03304054
What this trial is testing

Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG

Who this might be right for
Myasthenia Gravis, Generalized
Catalyst Pharmaceuticals, Inc. 93
Not applicableStudy completedNCT01927692
What this trial is testing

Therapeutic Plasma Exchange in MG

Who this might be right for
Myasthenia Gravis
Duke University 11
Large-scale testing (Phase 3)Active Not RecruitingNCT05556096
What this trial is testing

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 261
Large-scale testing (Phase 3)Study completedNCT00309088
What this trial is testing

FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients

Who this might be right for
Myasthenia Gravis
Astellas Pharma Inc 80
Not applicableLooking for participantsNCT03792659
What this trial is testing

The EXPLORE MG Registry for Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Yale University 800
Large-scale testing (Phase 3)Study completedNCT00309101
What this trial is testing

An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

Who this might be right for
Myasthenia Gravis
Astellas Pharma Inc 11
Early research (Phase 1)Looking for participantsNCT06626919
What this trial is testing

Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Who this might be right for
Muscular DiseasesNeuromuscular ManifestationsAutoimmune+4 more
Arcellx, Inc. 30
Load More Results